The Innovation Reduction Act with Allan Shaw
Business Of Biotech
00:00
The Impact of the IRA on Emerging Biotechs
Pfizer recently did an acquisition in acquired Seattle genetics, and they actually attributed the IRA is to some of the industrial logic associated with the transaction. So it gave them an advantage of again, allocating resources for things for products that will have a longer shelf life. That's the other aspect that I've observed in the short term that this law has been on the books.
Transcript
Play full episode
